×
About 33,180 results

ALLMedicine™ Psoriasis Center

Research & Reviews  9,692 results

Real-world evidence from the non-interventional, prospective, German multicentre PERSIS...
https://doi.org/10.1111/jdv.18218
Journal of the European Academy of Dermatology and Venere... Gerdes S, Asadullah K et. al.

May 16th, 2022 - PERSIST was a prospective, non-interventional, long-term, German multicentre study of patients with moderate-to-severe psoriasis receiving guselkumab, an approved monoclonal antibody that binds to the p19 subunit of interleukin (IL)-23, in a real-...

Cognitive Functions Associated with Brain Imaging Markers in Patients with Psoriasis.
https://doi.org/10.3390/ijerph19095687
International Journal of Environmental Research and Publi... Marek-Jozefowicz L, Lemanowicz A et. al.

May 15th, 2022 - Psoriasis is a severe inflammatory disease associated with a higher comorbidity of depression, cognitive dysfunction and brain atrophy. The association between psoriasis, magnetic resonance imaging (MRI) markers and cognitive impairment has rarely...

Retrospective study of apremilast drug survival in psoriasis patients in a daily practi...
https://doi.org/10.1111/dth.15583
Dermatologic Therapy; Galache-Osuna C, Reyes-García S et. al.

May 15th, 2022 - There is limited evidence about the real-world survival of apremilast in patients with psoriasis, especially over the long term. To evaluate the long-term survival of apremilast and its predictive factors when used to treat psoriasis. A retrospect...

Usefulness of Ultrasound Examination in the Assessment of the Nail Apparatus in Psoriasis.
https://doi.org/10.3390/ijerph19095611
International Journal of Environmental Research and Publi... Krajewska-Włodarczyk M, Owczarczyk-Saczonek A

May 15th, 2022 - The assessment of psoriatic nail changes in everyday practice is based exclusively on clinical symptoms that do not reflect the entire disease process in the nail apparatus. The use of imaging methods, especially widely available and inexpensive u...

Do Patients with Psoriatic Arthritis Have More Severe Skin Disease than Patients with P...
https://doi.org/10.1159/000524231
Dermatology (Basel, Switzerland); Pouw JN, Jacobs ME et. al.

May 14th, 2022 - Early identification of patients at risk of psoriatic arthritis (PsA) is essential to facilitate early diagnosis and improve clinical outcomes. Severe cutaneous psoriasis has been proposed to be associated with PsA, but a recent assessment of the ...

see more →

Guidelines  22 results

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specifi...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.

Feb 7th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway.
https://doi.org/10.1159/000512930
Dermatology (Basel, Switzerland); Maul JT, Anzengruber F et. al.

Jan 7th, 2021 - Topical treatment is crucial for the successful management of plaque psoriasis. Topicals are used either as a stand-alone therapy for mild psoriasis or else in combination with UV or systemic treatment for moderate-to-severe disease. For the choic...

Portuguese recommendations for the treatment of psoriasis with biologic therapy.
https://doi.org/10.1684/ejd.2020.3945
European Journal of Dermatology : EJD; Torres T, Tavares Bello R et. al.

Dec 11th, 2020 - Psoriasis is a highly prevalent chronic, inflammatory multisystem disease with a considerable impact on patients' quality of life and the healthcare system. This report presents the recommendations developed by the Portuguese Psoriasis Group of th...

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471802
Journal of the American Academy of Dermatology; Gelfand JM, Armstrong AW et. al.

Sep 7th, 2020 - To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic. A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and...

see more →

Drugs  897 results see all →

Clinicaltrials.gov  584 results

Anti-Inflammatory Effects of Time-Restricted Feeding
https://clinicaltrials.gov/ct2/show/NCT04728165

May 13th, 2022 - Study Rationale We have previously shown that fasting, and the caloric restriction mimetic nicotinamide riboside (NR) confer anti-inflammatory effects on a broad array of circulating innate and adaptive immune cells. Three major effects include fa...

Natural History and Development of Spondyloarthritis
https://clinicaltrials.gov/ct2/show/NCT01422694

May 13th, 2022 - The purpose of this protocol is to study the natural history of spondyloarthritis (SpA) in children and adults. Spondyloarthritis encompasses a spectrum of immune-mediated inflammatory diseases that exhibit overlapping features, but differ from ot...

Multi-Center PAMPA Study
https://clinicaltrials.gov/ct2/show/NCT05004727

May 13th, 2022 - This is a multi-center (North-America), randomized, double-blind, placebo-controlled, wait-list, interventional, preventive trial of guselkumab in high-risk psoriasis patients compared to non-biologic standard of care. The primary objective of our...

Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology
https://clinicaltrials.gov/ct2/show/NCT03366142

May 13th, 2022 - Lymphocyte adhesion deficiency type 1 (LAD1) is an autosomal recessive disorder of leukocyte function. Decreased expression of the <=2 subunit of leukocyte integrins results in abnormal cell-cell and cell extracellular matrix adhesion. This diseas...

Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis
https://clinicaltrials.gov/ct2/show/NCT04271735

May 13th, 2022 - Study Description: Psoriasis is a Th17 linked inflammatory disease and we find that the vitamin B3 analogue nicotinamide riboside (NR) blunts Th1 and Th17 activation in ex-vivo na(SqrRoot) ve and differentiated T cells from control and psoriasis s...

see more →

News  2,035 results

Topical Prescribing Tips for Better Psoriasis Outcomes
https://www.medscape.com/viewarticle/965162

May 5th, 2022 - This transcript has been edited for clarity. Steven R. Feldman, MD: Hi. I'm Dr Steve Feldman and welcome to Medscape InDiscussion. Today, we're talking about psoriasis and the most important things to know about psoriasis treatment — using topical...

IL-17 inhibitors associated with higher treatment persistence in PsA
https://www.mdedge.com/dermatology/article/253998/psoriatic-arthritis/il-17-inhibitors-associated-higher-treatment

Apr 25th, 2022 - Key clinical point: Interleukin-17 (IL-17) inhibitors were associated with higher treatment persistence than tumor necrosis factor (TNF) inhibitors or IL-12/23 inhibitors in patients with psoriatic arthritis (PsA) who initiated treatment with biol.

Long-term Efficacy, Safety Data for Ixekizumab in Pediatric Psoriasis Reported
https://www.medscape.com/viewarticle/972678

Apr 25th, 2022 - Two-year follow-up data from an international, multicenter, randomized trial of ixekizumab in pediatric patients with moderate to severe psoriasis demonstrate prolonged efficacy and no new safety signals with the interleukin (IL)-17 inhibitor, inv...

Skill Checkup: A 32-Year-Old Woman With Several Thick, Scaly, Well-Defined, Erythematous Plaques
https://www.medscape.com/viewarticle/971361

Apr 20th, 2022 - The Skill Checkup series provides a quick, case-style interactive quiz, highlighting key guideline- and evidence-based information to inform clinical practice. A 32-year-old woman presents with several thick, scaly, well-defined, erythematous plaq...

Hypocaloric Diet Controls Joint Activity in Psoriatic Arthritis, Regardless of Weight Loss
https://www.medscape.com/viewarticle/972197

Apr 14th, 2022 - A 12-week hypocaloric diet provided suitable control of joint disease activity in patients with psoriatic arthritis (PsA), regardless of weight loss, Brazilian researchers found. Earlier research has reported that weight loss improves the symptoms...

see more →

Patient Education  42 results see all →